Damjan Avsec

1. AVSEC, Damjan, FLEGAR, Ines. Gensko zdravljenje Huntingtonove bolezni = Gene therapy for Huntington's disease. Farmacevtski vestnik : strokovno glasilo slovenske farmacije. [Tiskana izd.]. 2016, vol. 67, št. 1, str. 374-379, ilustr. ISSN 0014-8229. http://www.sfd.si/uploads/datoteke/avsec.pdf, http://www.dlib.si/details/URN:NBN:SI:DOC-KTS8RJS4. [COBISS.SI-ID 30044711]

2. MARKOVIČ, Tijana, PODGORNIK, Helena, DELIČ, Jozo, VRBEK, Sanja, AVSEC, Damjan, MLINARIČ-RAŠČAN, Irena. Chronic lymphocytic leukemia cells as an in vitro model in preclinical drug evaluation. ALTEX Proceedings. str. 150. ISSN 2194-0479. http://eusaat-congress.eu/images/2018/PDF/Abstractbook_Linz_2018_EUSAAT_2018_e_version.pdf. [COBISS.SI-ID 4615793]

3. AVSEC, Damjan. Sinergistično delovanje ibrutiniba in idelalisiba z agonisti receptorja EP4 na celicah kronične limfocitne levkemije = Synergistic effects of ibrutinib and idelalisib with EP4 receptor agonists on chronic lymphocytic leukemia cells : enoviti magistrski študijski program Farmacija. Ljubljana: [D. Avsec], 2018. XII, 66 f., I-X f. pril., tabele, graf. prikazi. Repository of the University of Ljubljana – RUL . [COBISS.SI-ID 4534385]

4. AVSEC, Damjan. Sinergistično delovanje ibrutiniba in idelalisiba z agonisti receptorja EP4 na celicah kronične limfocitne levkemije = Synergistic effects of ibrutinib and idelalisib with EP4 receptor agonists on chronic lymphocytic leukemia cells : Prešernove nagrade študentom. Ljubljana: [D. Avsec], 2018. XII, f 1-66, I-X f. pril., graf. prikazi, tabele. [COBISS.SI-ID 4647793]

5. AVSEC, Damjan, MLINARIČ-RAŠČAN, Irena. Autophagy is a prosurvival pathway in chronic lymphocytic leukemia. In: KISOVEC, Matic (ed.). Book of abstracts = Knjiga povzetkov. 13th Meeting of the Slovenian Biochemical Society with International Participation = 13. srečanje Slovenskega biokemijskega društva z mednarodno udeležbo, Dobrna, 24 - 27 September 2019. Ljubljana: Slovenian Biochemical Society, 2019. Str. 151. ISBN 978-961-93879-8-6. [COBISS.SI-ID 4804465]

6. AVSEC, Damjan, MLINARIČ-RAŠČAN, Irena. Co-targeting autophagy and ubiquitin-proteasome system as a new therapeutic strategy for chronic lymphocytic leukemia. In: 18th International Summer School, July 28 - 30, 2019, Bönigen. Bönigen: [s. n.], 2019. 1 str. [COBISS.SI-ID 4760177]

7. AVSEC, Damjan, GOBEC, Martina, MLINARIČ-RAŠČAN, Irena. Development of carfilzomib resistant in vitro model of chronic lymphocytic leukemia. In: REŽEN, Tadeja (ed.). Book of abstracts. 1st electronic ed. Ljubljana: University of Ljubljana, Faculty of Medicine, 2019. 1 str. ISBN 978-961-267-161-7. http://cfgbc.mf.uni-lj.si/events/seminars/2019cfgbcsym14/abstracts/posterAbstract_DAvsec.html. [COBISS.SI-ID 4783473]

8. AVSEC, Damjan, GOBEC, Martina, MLINARIČ-RAŠČAN, Irena. Development of carfilzomib resistant in vitro model of chronic lymphocytic leukemia. In: REŽEN, Tadeja (ed.). Book of abstracts. 1st electronic ed. Ljubljana: University of Ljubljana, Faculty of Medicine, 2019. 1 str. ISBN 978-961-267-161-7. http://cfgbc.mf.uni-lj.si/2019eracosysmed/. [COBISS.SI-ID 4742513]

9. AVSEC, Damjan, GOBEC, Martina, DELIČ, Jozo, MLINARIČ-RAŠČAN, Irena. Overcoming resistance in chronic lymphocytic leukemia with selective immunoproteasome inhibition. In: WINnovation and Global Deployment of Precision Oncology : general information and program. [S. l.]: [s. n.], 2019. 1 str. [COBISS.SI-ID 4742257]

10. NABERGOJ, Sanja, AVSEC, Damjan, MARKOVIČ, Tijana, GOBEC, Martina, JAKOPIN, Žiga, PODGORNIK, Helena, DELIČ, Jozo, MLINARIČ-RAŠČAN, Irena. Prostaglandin E receptor 4 agonists as potential therapeutic agents for treatment of chronic lymphocytic leukemia. In: WINnovation and Global Deployment of Precision Oncology : general information and program. [S. l.]: [s. n.], 2019. 1 str. [COBISS.SI-ID 4742001]

11. NABERGOJ, Sanja, GODEC, Matej, AVSEC, Damjan, MARKOVIČ, Tijana, GOBEC, Martina, JAKOPIN, Žiga, PODGORNIK, Helena, DELIČ, Jozo, MLINARIČ-RAŠČAN, Irena. Prostaglandin E receptor 4 agonists as potential therapeutic agents in therapy of chronic lymphocytic leukemia. In: 18th International Summer School, July 28 - 30, 2019, Bönigen. Bönigen: [s. n.], 2019. 1 str. [COBISS.SI-ID 4760433]

12. AVSEC, Damjan, URBANČIČ, Dunja. Analiza polimorfizmov dolžin restrikcijskih fragmentov. E-učbenik : vaje pri predmetu Celična biologija z genetiko. Ljubljana: Univerza v Ljubljani, Fakulteta za farmacijo, 2020. 1 USB ključ, barve, zvok. https://visffa.uni-lj.si/. [COBISS.SI-ID 20707075]

13. AVSEC, Damjan, ŠKRLJ, Marja, MLINARIČ-RAŠČAN, Irena. Delineating the signaling pathways implicated in venetoclax resistance in chronic lymphocytic leukemia. In: 22nd EMBL PhD Symposium, EMBL Heidelberg, Germany, 27-28 November 2020 : the roaring 20s - a new decade for life sciences confirmation ; [virtual symposium]. [S. l.]: [s. n.], 2020. 1 str., ilustr. http://phdsymposium.embl.org/#programme. [COBISS.SI-ID 39975683]

14. AVSEC, Damjan, ŠKRLJ, Marja, MLINARIČ-RAŠČAN, Irena. Delineating the signaling pathways implicated in venetoclax resistance in chronic lymphocytic leukemia. In: Abstracts. 14th CFGBC Symposium, June 11th 2019, Faculty of Medicine, University of Ljubljana, Ljubljana. Ljubljana: Faculty of Medicine, 2019. http://cfgbc.mf.uni-lj.si/events-2020cfgbcsym15/events-2020cfgbcsym15-posterabstracts/. [COBISS.SI-ID 19747587]

15. URBANČIČ, Dunja, AVSEC, Damjan. Izolacija DNA. E-učbenik : vaje pri predmetu Celična biologija z genetiko. Ljubljana: Univerza v Ljubljani, Fakulteta za farmacijo, 2020. 1 USB ključ, barve, zvok. https://visffa.uni-lj.si/. [COBISS.SI-ID 21944323]

16. OMERSEL, Jasna, ŠMID, Alenka, ZORE, Taja, SLAVEC, Lara, AVSEC, Damjan, PRODAN ŽITNIK, Irena, OSREDKAR, Joško, BOŽIČ, Borut, MARC, Janja. Laboratorijska diagnostika covid-19 : od dokazovanja okužbe do merjenja imunskega odziva = Laboratory diagnosis of covid-19 : from virus detection to immune response measurement. Farmacevtski vestnik : strokovno glasilo slovenske farmacije. [Tiskana izd.]. 2020, letn. 71, št. 2, str. 112-120, ilustr. ISSN 0014-8229. http://www.sfd.si/uploads/datoteke/2fv2_112120.pdf, http://www.dlib.si/details/URN:NBN:SI:doc-40CRRTFQ. [COBISS.SI-ID 20695043]

17. AVSEC, Damjan, URBANČIČ, Dunja. Priprava agaroznega gela in elektroforezna ločba. E-učbenik : vaje pri predmetu Celična biologija z genetiko. Ljubljana: Univerza v Ljubljani, Fakulteta za farmacijo, 2020. 1 USB ključ, barve, zvok. https://visffa.uni-lj.si/. [COBISS.SI-ID 20707587]

18. AVSEC, Damjan, MLINARIČ-RAŠČAN, Irena. Selective immunoproteasome inhibition complements the action of contemporary targeted therapy in chronic lymphocytic leukemia. In: Translational medicine explained : registration open for 5-day online course, Amsterdam, October 26 - 30, 2020. [5] str. https://drive.google.com/file/d/1zJb8QeX_7yU97dh364GEJq3H7gexHJjM/view. [COBISS.SI-ID 35107075]

19. AVSEC, Damjan, ŠKRLJ, Marja, MLINARIČ-RAŠČAN, Irena. Selektivno zaviranje imunoproteasoma v premagovanju odpornosti kronične limfocitne levkemije na sodobna tarčna zdravila. In: BAVEC, Aljoša (ed.), et al. BIOmolekularec.si : Dan biomolekularnih znanosti : zbornik povzetkov : Ljubljana, 24. september 2020 : [spletna izvedba dogodka]. Ljubljana: Slovensko biokemijsko društvo, 2020. Str. 23. ISBN 978-961-93879-9-3. http://biomolekularec.splet.arnes.si/files/2020/09/BIOmolekularec_2020-zbornik.pdf. [COBISS.SI-ID 29990915]

20. URBANČIČ, Dunja, AVSEC, Damjan. Verižna reakcija s polimerazo (PCR). E-učbenik : vaje pri predmetu Celična biologija z genetiko. Ljubljana: Univerza v Ljubljani, Fakulteta za farmacijo, 2020. 1 USB ključ, barve, zvok. https://visffa.uni-lj.si/. [COBISS.SI-ID 21945347]

21. AVSEC, Damjan, MLINARIČ-RAŠČAN, Irena. Zdravljenje kronične limfocitne levkemije. Spatula : glasilo Študentske sekcije Slovenskega farmacevtskega društva. 2020, št. 81, str. 4-8, ilustr. ISSN 1408-7650. [COBISS.SI-ID 4892785]

22. NABERGOJ, Sanja, MARKOVIČ, Tijana, AVSEC, Damjan, GOBEC, Martina, PODGORNIK, Helena, JAKOPIN, Žiga, MLINARIČ-RAŠČAN, Irena. EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cells. Biochemical pharmacology. [Print ed.]. 2021, vol. 183, str. 1-14, ilustr. ISSN 0006-2952. https://www.sciencedirect.com/science/article/pii/S0006295220305888#!, Repository of the University of Ljubljana – RUL , DOI: 10.1016/j.bcp.2020.114352. [COBISS.SI-ID 43415299]
project: P1-0208; funder: ARRS
project: NC-0004; funder: ARRS
project: funder: European Regional Development Plan

23. ŠKRLJ, Marja. Preučevanje mehanizmov odpornosti celic kronične limfocitne levkemije na venetoklaks = Investigation of venetoclax resistance mechanisms in chronic lymphocytic leukemia cells : enoviti magistrski študijski program Farmacija. Ljubljana: [M. Škrlj Miklavčič], 2021. VIII, 64 str., I-II f. pril., ilustr., graf. prikazi. [COBISS.SI-ID 67697155]

24. ŠKRLJ, Marja. Proučevanje mehanizmov odpornosti celic kronične limfocitne levkemije proti venetoklaksu = Investigating the mechanisms of resistance of chronic lymphocytic leukemia cells to venetoclax. In: 51. Krkine nagrade : 31. simpozij : zbornik povzetkov = 51st Krka prizes : 31st Symposium : book of abstracts : [Novo mesto, 15. oktober 2021]. 51. Krkine nagrade, 31. simpozij = 51st Krka prizes, 31st Symposium, Novo mesto, 15. oktober 2021. Novo mesto: Krka, 2021. Str. 77. http://krkinenagrade-ext.tm.si/media/store/175701-2021-51-KN-Book-abstracts-SI-EN.pdf. [COBISS.SI-ID 81688323]

25. WANG, Xiaoliang, AVSEC, Damjan, OBREZA, Aleš, YOUSEFI, Shida, MLINARIČ-RAŠČAN, Irena, SIMON, Hans-Uwe. A putative serine protease is required to initiate the RIPK3-MLKL-mediated necroptotic death pathway in neutrophils. Frontiers in pharmacology. 2021, vol 11, str. 1-10, graf. prikazi. ISSN 1663-9812. https://www.frontiersin.org/articles/10.3389/fphar.2020.614928/full, Repository of the University of Ljubljana – RUL , DOI: 10.3389/fphar.2020.614928. [COBISS.SI-ID 48117763]
project: 31003A_173215 to SY. and 310030_184816 to H-US; funder: Swiss National Science Foundation
project: 642295; funder: European Union Horizon 2020 Research and Innovation Program
project: P2-0208; funder: ARRS

26. JAKOŠ DJORDJEVIČ, Alma Tana. Targeting autophagy complements the action of ibrutnib and venetoclax in chronic lymphocytic leukemia cells. EPSA studentsʹ science publication. 2021, vol. 9, ed. 1, str. 8-9. https://issuu.com/epsaonline/docs/essp9v1final. [COBISS.SI-ID 81806595]

27. AVSEC, Damjan, JAKOŠ DJORDJEVIČ, Alma Tana, KANDUŠER, Maša, PODGORNIK, Helena, ŠKERGET, Matevž, MLINARIČ-RAŠČAN, Irena. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cells. Cancers. Jul. 2021, vol. 13, iss. 18, str. 1-20, ilustr. ISSN 2072-6694. https://www.mdpi.com/2072-6694/13/18/4557, Repository of the University of Ljubljana – RUL , DOI: 10.3390/cancers13184557. [COBISS.SI-ID 76337667]
project: P1-0208; funder: Slovenian Research Agency
project: NC-0004; funder: ARRS
project: P3-0289; funder: ARRS
project: EATRIS-TRI.SI; funder: European Regional Development Plan

28. AVSEC, Damjan, JAKOŠ DJORDJEVIČ, Alma Tana, PODGORNIK, Helena, MLINARIČ-RAŠČAN, Irena. Targeting autophagy via AMPK/ULK1/2 pathway inhibition affects survival and therapeutic susceptibility of chronic lymphocytic leukemia cells : 45th FEBS Congress, Molecules of Life: Towards New Horizons, Ljubljana, Slovenia, July 3-8, 2021. FEBS open bio. 2021, vol. 11, issue s1, str. 161. ISSN 2211-5463. https://febs.onlinelibrary.wiley.com/doi/10.1002/2211-5463.13205, DOI: 10.1002/2211-5463.13205. [COBISS.SI-ID 69770755]

29. JAKOŠ DJORDJEVIČ, Alma Tana. Vloga avtofagije v terapevtski občutljivosti celic kronične limfocitne levkemije = The role of autophagy in the therapeutic susceptibility of chronic lymphocytic leukemia cells : magistrska naloga : enoviti magistrski študijski program Farmacija. Ljubljana: [A. T. Jakoš Djordjevič], 2021. XI, 54 str, ilustr. https://repozitorij.uni-lj.si/IzpisGradiva.php?id=126305. [COBISS.SI-ID 59935491]

30. OBREZA, Aleš, POROVNE ČERNE, Nina, KOŠČAK, Sara, SKALA, Špela, AVSEC, Damjan, KANDUŠER, Maša, MLINARIČ-RAŠČAN, Irena. Design, synthesis and biochemical evaluation of lowmolecular- weight human neutrophil elastase inhibitors : keynote lectures. In: OBREZA, Aleš (ed.), et al. 9th BBBB International Conference on Pharmaceutical Sciences : Pharma sciences of tomorrow : book of abstracts : Ljubljana, Slovenia, 15th-17th September, 2022. Ljubljana: Slovensko farmacevtsko društvo: Fakulteta za farmacijo, 2022. Str. 31-32, kl5, ilustr. ISBN 978-961-94230-4-2. https://bbbb2022.sfd.si/wp-content/uploads/2020/08/9th-bbbb-conference-book-of-abstracts.pdf. [COBISS.SI-ID 122212611]

31. KENDA, Maša, AVSEC, Damjan, ZORE, Taja, KOGOVŠEK, Eva, PEČAR FONOVIĆ, Urša, KOS, Janko, BOZOVIČAR, Krištof, BRATKOVIČ, Tomaž, KARAS KUŽELIČKI, Nataša, ŽEGURA, Bojana, FILIPIČ, Metka, SOLLNER DOLENC, Marija. Effects of tyrosine kinase inhibitors on androgen, estrogen ▫$\alpha$▫ glucocorticoid and thyroid receptors. Toxicology and applied pharmacology. 2022, vol. 434, str. 1-10, graf. prikazi. ISSN 0041-008X. https://www.sciencedirect.com/science/article/pii/S0041008X21004221, DOI: 10.1016/j.taap.2021.115818. [COBISS.SI-ID 88548099]
project: J1-8140, P1-0208; funder: ARRS

32. MARKOVIČ, Tijana, PODGORNIK, Helena, AVSEC, Damjan, NABERGOJ, Sanja, MLINARIČ-RAŠČAN, Irena (author, corresponding author). The enhanced cytotoxic effects in B-cell leukemia and lymphoma following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodies. International journal of molecular sciences. 2022, vol. 23, iss. 3, str. 1-19, ilustr. ISSN 1422-0067. https://www.mdpi.com/1422-0067/23/3/1599, Repository of the University of Ljubljana – RUL , DOI: 10.3390/ijms23031599. [COBISS.SI-ID 96734467]
project: funder: ARRS
project: OP20.05187 RI-SI-EATRIS; funder: the Ministry of Education, Science, and Sport (MIZŠ) and the European Regional Development Fund

33. MARKOVIČ, Tijana, PODGORNIK, Helena, AVSEC, Damjan, NABERGOJ, Sanja, MLINARIČ-RAŠČAN, Irena. The enhanced cytotoxic effects in chronic lymphocytic leukemia cells following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodies. In: E-Conference : E-Conference - #ESHCLL2022. Paris: [s. n.], 2022. Str. 134, ilustr. https://chronic-lymphocytic-leukaemia-2022.esh.live/e-book/. [COBISS.SI-ID 100805123]

34. AVSEC, Damjan, ŠKRLJ MIKLAVČIČ, Marja, BURNIK, Tilen, KANDUŠER, Maša, BIZJAK, Maruša, PODGORNIK, Helena, MLINARIČ-RAŠČAN, Irena. Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax. Cell death & disease. 2022, vol. 13, art. 860, 13 str., ilustr. ISSN 2041-4889. https://www.nature.com/articles/s41419-022-05287-6, Repository of the University of Ljubljana – RUL , DOI: 10.1038/s41419-022-05287-6. [COBISS.SI-ID 124912643]
award: Mentorica pri članku Irena Mlinarič-Raščan, somentorica Helena Podgornik.
project: P1-0208 Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin; funder: ARRS
project: NC-0004 NOBIL - Novi biološki označevalci v levkemiji; funder: ARRS
project: P3-0289 Značilnosti malignih neoplazem, pomembne za diagnozo ter napoved poteka bolezni in izida zdravljenja; funder: ARRS
project: OP20.05187 [RI-SI-EATRIS]; funder: Ministry of Education, Science, and Sport (MIZŠ) and the European Regional Development Fund

35. MARKOVIČ, Tijana, ŠMID, Alenka, PODGORNIK, Helena, AVSEC, Damjan, MLINARIČ-RAŠČAN, Irena. Prostaglandinski receptor EP4 – nov potencialni biomarker in terapevtska tarča v kronični limfocitni levkemiji = Prostaglandin EP4 receptor as a potencial novel biomarker and therapeutic target in chronic lymphocytic leukemia. Laboratorijska medicina : znanstveno-strokovno glasilo Slovenskega združenja za klinično kemijo in laboratorijsko medicino. [Tiskana izd.]. sep. 2022, št. 4, str. 137. ISSN 2670-4463. https://www.szkklm.si/assets/images/upload/Revija_LM/LM-04_2022.pdf, http://www.dlib.si/details/URN:NBN:SI:doc-263GUYGV. [COBISS.SI-ID 122187267]

36. MLINARIČ-RAŠČAN, Irena, AVSEC, Damjan, PODGORNIK, Helena, MARKOVIČ, Tijana. Sinergistično citotoksično delovanje zaviranja imunoproteasom/NF▫$\kappa$▫B signalne poti s tarčnimi zdravili pri tretiranju celic KLL ex vivo. In: 40. strokovni sestanek Hematološkega laboratorijskega združenja : zbornik predavanj : Terme Olimia, 25. in 26. marec 2022. Ljubljana: Hematološko laboratorijsko združenje, 2022. Str. 20-21, ilustr. ISBN 978-961-94292-7-3. [COBISS.SI-ID 104707843]

37. BURNIK, Tilen. Sinergistično delovanje zaviralcev proteasoma in imunoproteasoma z zaviralci receptorske poti limfocitov B na celicah kronične limfocitne levkemije = Synergistic activity of proteasome and immunoproteasome inhibitors with B-cell receptor pathway inhibitors in chronic lymphocytic leukemia cells : delo za Prešernovo nagrado. Ljubljana: [T. Burnik], 2022. X, 66 f, I-VI f. pril., ilustr., tabele. [COBISS.SI-ID 174491139]

38. BURNIK, Tilen. Sinergistično delovanje zaviralcev proteasoma in imunoproteasoma z zaviralci receptorske poti limfocitov B na celicah kronične limfocitne levkemije = Synergistic activity of proteasome and immunoproteasome inhibitors with B-cell receptor pathway inhibitors in chronic lymphocytic leukemia cells : enoviti magistrski študijski program Farmacija. Ljubljana: [T. Burnik], 2022. X, 66 str. I-VI f. pril., tabele, graf. prikazi. [COBISS.SI-ID 123745027]
project: BI-FR/CEA/18-20-004 CEA NOBIL

39. AVSEC, Damjan, PODGORNIK, Helena, MLINARIČ-RAŠČAN, Irena. Tarčno zdravljenje kronične limfocitne levkemije z antagonisti antiapoptotičnih proteinov = Antagonists of antiapoptotic proteins in the targeted therapy of chronic lymphocytic leukemia. Farmacevtski vestnik : strokovno glasilo slovenske farmacije. [Tiskana izd.]. mar. 2022, letn. 73, št. 1, str. 31-39, ilustr. ISSN 0014-8229. http://www.dlib.si/details/URN:NBN:SI:doc-JEU4H14X. [COBISS.SI-ID 103039747]

40. AVSEC, Damjan, PODGORNIK, Helena, ŠKERGET, Matevž, MLINARIČ-RAŠČAN, Irena. Tarčno zdravljenje kronične limfocitne levkemije z zaviralci Brutonove tirozin kinaze = Targeting Bruton’s tyrosine kinase in chronic lymphocytic leukemia. Farmacevtski vestnik : strokovno glasilo slovenske farmacije. [Tiskana izd.]. 2022, letn. 73, št. 5, str. 410-417, ilustr. ISSN 0014-8229. https://www.sfd.si/wp-content/uploads/2022/12/damjan-avsec.pdf, http://www.dlib.si/details/URN:NBN:SI:doc-V5C321IC. [COBISS.SI-ID 132626435]

41. AVSEC, Damjan. The cytotoxic potential of targeting immunoproteasome/NFκB in chronic lymphocytic leukemia. In: NADIŽAR, Nejc (ed.). 17th CFGBC Symposium : book of abstracts : Hybrid Symposium Slovenia, 6th June 2022. Electronic version. Ljubljana: Faculty of Medicine, 2022. Str. 13. http://cfgbc.mf.uni-lj.si/wp-content/uploads/bookofabstracts_2022cfgbcsym17.pdf. [COBISS.SI-ID 110679299]

42. JELESIJEVIČ, Špela. Vloga avtofagije pri odpornosti celic kronične limfocitne levkemije na zaviralce receptorske poti celic B = The role of autophagy in the resistance of chronic lymphocytic leukemia cells to the B-cell receptor pathway inhibitors : enoviti magistrski študijski program Farmacija. Ljubljana: [Š. Jesenijevič], 2022. X, 52 f., tabele, graf. prikazi. [COBISS.SI-ID 114079747]

43. AVSEC, Damjan. Zaviranje p38 MAPK ali imunoproteasoma premosti odpornosti celic kronične limfocitne levkemije na antagonist Bcl-2-venetoklaks : predavanje v okviru Tedna Univerze v Ljubljani na Fakulteti za farmacijo, Ljubljana, 30. november 2022. [COBISS.SI-ID 131516419]

44. MARKOVIČ, Tijana, PODGORNIK, Helena, ŠMID, Alenka, AVSEC, Damjan, MLINARIČ-RAŠČAN, Irena. EP4 receptor agonist is cytotoxic to chronic lymphocytic leukemia cells and acts synergistically with ibrutinib and idelalisb : [poster presentations]. In: OSREDKAR, Joško (ed.). Book of Abstracts : 46th ISOBM Congress 13th - 17th October, Bled, Slovenia. Basel: [S. Karger], 2023. Str. s53. Tumor Biology (Online), Vol.46, iss. s1. ISSN 1010-4283. https://content.iospress.com/download/tumor-biology/tub239004?id=tumor-biology%2Ftub239004, DOI: 10.3233/TUB-239004. [COBISS.SI-ID 155348227]

45. AVSEC, Damjan, BURNIK, Tilen, KANDUŠER, Maša, MLINARIČ-RAŠČAN, Irena. Inhibition of proteasome and immunoproteasome synergizes with targeted therapy against chronic lymphocytic leukemia cells : [oral presentations]. In: OSREDKAR, Joško (ed.). Book of Abstracts : 46th ISOBM Congress 13th - 17th October, Bled, Slovenia. Basel: [S. Karger], 2023. Str. s29-s30. Tumor Biology (Online), Vol.46, iss. s1. ISSN 1010-4283. https://content.iospress.com/download/tumor-biology/tub239003?id=tumor-biology%2Ftub239003, DOI: :10.3233/TUB-239003. [COBISS.SI-ID 155345667]

46. DRAGOVIĆ, Anđela. Preučevanje mehanizmov odpornosti celic kronične limfocitne levkemije na sodobno terapijo = Investigating the resistance mechanisms of chronic lymphocytic leukemia cells towards contemporary therapies : enoviti magistrski študijski program Farmacija. Ljubljana: [A. Dragović], 2023. IX, 64 str., i fol. pril., ilustr. [COBISS.SI-ID 164791299]

47. AVSEC, Damjan. The role of proteasome, immunoproteasome and autophagy in the therapy of chronic lymphocytic leukemia = Vloga proteasoma, imunoproteasoma in avtofagije v terapiji kronične limfocitne levkemije : doctoral dissertation. Ljubljana: [D. Avsec], 2023. 317 str., ilustr. [COBISS.SI-ID 167069187]
project: P1-0208; funder: ARRS
project: NC-0004; funder: ARRS
project: OP20.05187 RI-SI-EATRIS; funder: MIZŠ and the European Regional Development Fund

48. BURNIK, Tilen. Sinergistično delovanje zaviralcev proteasoma in imunoproteasoma z zaviralci receptorske poti limfocitov B na celicah kronične limfocitne levkemije = Synergistic activity of proteasome and immunoproteasome inhibitors with B-cell receptor pathway inhibitors in chronic lymphocytic leukemia cells. In: PLEVNIK, Miha (ed.), OBERSTAR FALKNER, Maja, GORJUP, Simona. 53. Krkine nagrade = 53nd Krka Prizes : zbornik povzetkov = book of abstracts : 33. simpozij = 33rd symposium : [Novo mesto, 20. oktober 2023]. Novo mesto: Krka, [2023]. Str. 76. [COBISS.SI-ID 171870211]

49. AVSEC, Damjan, PODGORNIK, Helena, ŠKERGET, Matevž, MLINARIČ-RAŠČAN, Irena. Tarčno zdravljenje kronične limfocitne levkemije z zaviralci fosfatidilinozitol 3-kinaze targeting = Phosphatidylinositol 3-kinase in chronic lymphocytic leukemia. Farmacevtski vestnik : strokovno glasilo slovenske farmacije. [Tiskana izd.]. mar. 2023, letn. 74, št. 1, str. 67-74, ilustr. ISSN 0014-8229. https://www.sfd.si/wp-content/uploads/2023/02/fv-1-2023_8.pdf, http://www.dlib.si/details/URN:NBN:SI:doc-3U3XM157. [COBISS.SI-ID 144693763]

50. AVSEC, Damjan. Vloga proteasoma, imunoproteasoma in avtofagije v terapiji kronične limfocitne levkemije = Role of proteasome, immunoproteasome, and autophagy in therapy of chronic lymphocytic leukaemia. In: PLEVNIK, Miha (ed.). 54. Krkine nagrade : 34. simpozij : zbornik povzetkov = 54th Krka prizes : 34th Symposium : book of abstracts : [Novo mesto, 18. oktober 2024]. 54. Krkine nagrade, 34. simpozij = 54th Krka prizes, 34th Symposium, Novo mesto, 18. oktober 2024. Novo mesto: Krka, 2024. Str. 69. https://www.krkinenagrade.si/media/store/54-KN/FINAL_544004-2024-KN-Krka-prizes-Book-of-abstracts-SI-EN.pdf. [COBISS.SI-ID 213162243]

Damjan Avsec

Personal bibliography for the period 2016-2024

2016

2018

2019

2020

2021

2022

2023

2024